Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score N/A
- Piotroski Score N/A
- Grade Perform
- Symbol (PHAS)
- Company PhaseBio Pharmaceuticals, Inc.
- Price $0.07
- Changes Percentage (0%)
- Change -$0
- Day Low $0.07
- Day High $0.09
- Year High $0.09
PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel for cardiovascular diseases. Its lead product candidate is bentracimab (PB2452), a reversal agent for the antiplatelet drug ticagrelor that is in Phase III clinical trial for patients with uncontrolled major or life-threatening bleeding events or in patients requiring urgent or an invasive procedure. The company is also developing PB1046, a vasoactive intestinal peptide analogue for the treatment of pulmonary arterial hypertension; and PB6440 for the treatment of resistant hypertension. The company has a co-development agreement with SFJ Pharmaceuticals X, Ltd. to develop PB2452, a reversal agent for the antiplatelet drug ticagrelor. PhaseBio Pharmaceuticals, Inc. was incorporated in 2002 and is based in Malvern, Pennsylvania. On October 23, 2022, PhaseBio Pharmaceuticals, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) N/A
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.38
- Trailing P/E Ratio -0.03
- Forward P/E Ratio -0.03
- P/E Growth -0.03
- Net Income $-131,071
Income Statement
Quarterly
Annual
Latest News of PHAS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Challenging next phase of Fukushima nuclear plant cleanup begins with robot set to gather nuclear fuel debris
An extendable robot has begun a mission to retrieve melted fuel debris from Fukushima Daiichi nuclear plant's damaged reactor. This marks a crucial phase in the decades-long decommissioning process, a...
By CBS News | 22 hours ago -
Australia to Phase Out AT1 Bonds for Bank Capital After Credit Suisse Wipeout
Australia's banking regulator aims to strengthen capital holdings by phasing out AT1 bonds after Credit Suisse's collapse. The proposal seeks to simplify bank resolution during crises and enhance depo...
By Yahoo! Finance | 1 day ago -
New York Times podcast says Harris' honeymoon phase is over, 'wave of euphoria' has faded after new poll
Former President Trump criticizes Vice President Kamala Harris as 'incompetent' while leading in polls against her. Harris faces challenges in gaining voter support, especially among key demographics ...
By Fox News | 1 day ago
